Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
6718 | 1377 | 29.7 | 82% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
618 | 13204 | HAEMOPHILIA//HAEMOPHILIA A//VON WILLEBRAND DISEASE |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | RFVIIA | Author keyword | 196 | 70% | 12% | 163 |
2 | RECOMBINANT ACTIVATED FACTOR VII | Author keyword | 184 | 71% | 11% | 148 |
3 | RECOMBINANT FACTOR VIIA | Author keyword | 146 | 59% | 12% | 162 |
4 | NOVOSEVEN | Author keyword | 94 | 85% | 4% | 50 |
5 | FACTOR VIIA | Author keyword | 42 | 32% | 8% | 106 |
6 | RECOMBINANT FVIIA | Author keyword | 38 | 65% | 3% | 36 |
7 | RECOMBINANT ACTIVATED FACTOR VII RFVIIA | Author keyword | 32 | 78% | 2% | 21 |
8 | NOVOSEVEN R | Author keyword | 29 | 88% | 1% | 14 |
9 | BYPASSING AGENTS | Author keyword | 24 | 60% | 2% | 26 |
10 | RECOMBINANT ACTIVATED FVII | Author keyword | 21 | 85% | 1% | 11 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | RFVIIA | 196 | 70% | 12% | 163 | Search RFVIIA | Search RFVIIA |
2 | RECOMBINANT ACTIVATED FACTOR VII | 184 | 71% | 11% | 148 | Search RECOMBINANT+ACTIVATED+FACTOR+VII | Search RECOMBINANT+ACTIVATED+FACTOR+VII |
3 | RECOMBINANT FACTOR VIIA | 146 | 59% | 12% | 162 | Search RECOMBINANT+FACTOR+VIIA | Search RECOMBINANT+FACTOR+VIIA |
4 | NOVOSEVEN | 94 | 85% | 4% | 50 | Search NOVOSEVEN | Search NOVOSEVEN |
5 | FACTOR VIIA | 42 | 32% | 8% | 106 | Search FACTOR+VIIA | Search FACTOR+VIIA |
6 | RECOMBINANT FVIIA | 38 | 65% | 3% | 36 | Search RECOMBINANT+FVIIA | Search RECOMBINANT+FVIIA |
7 | RECOMBINANT ACTIVATED FACTOR VII RFVIIA | 32 | 78% | 2% | 21 | Search RECOMBINANT+ACTIVATED+FACTOR+VII+RFVIIA | Search RECOMBINANT+ACTIVATED+FACTOR+VII+RFVIIA |
8 | NOVOSEVEN R | 29 | 88% | 1% | 14 | Search NOVOSEVEN+R | Search NOVOSEVEN+R |
9 | BYPASSING AGENTS | 24 | 60% | 2% | 26 | Search BYPASSING+AGENTS | Search BYPASSING+AGENTS |
10 | RECOMBINANT ACTIVATED FVII | 21 | 85% | 1% | 11 | Search RECOMBINANT+ACTIVATED+FVII | Search RECOMBINANT+ACTIVATED+FVII |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | RFVIIA | 335 | 81% | 15% | 204 |
2 | NOVOSEVENR | 205 | 80% | 9% | 129 |
3 | ACTIVATED FACTOR VII | 198 | 34% | 35% | 479 |
4 | DOSE FACTOR VIIA | 116 | 73% | 7% | 90 |
5 | RECOMBINANT FACTOR VIIA | 79 | 23% | 22% | 302 |
6 | NOVOSEVEN | 60 | 75% | 3% | 43 |
7 | FACTOR VLLA | 58 | 92% | 2% | 23 |
8 | BLEEDING EPISODES | 44 | 58% | 4% | 51 |
9 | FVIIA | 40 | 76% | 2% | 28 |
10 | CELL BASED MODEL | 37 | 55% | 3% | 46 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Systematic Review: Benefits and Harms of In-Hospital Use of Recombinant Factor VIIa for Off-Label Indications | 2011 | 90 | 84 | 76% |
Recombinant activated factor VII in cardiac surgery: A systematic review | 2007 | 73 | 64 | 77% |
Recombinant factor VIIa: review of efficacy, dosing regimens and safety in patients with congenital and acquired factor VIII or IX inhibitors | 2004 | 176 | 56 | 79% |
The use of recombinant factor VIIa in the treatment of bleeding disorders | 2004 | 160 | 65 | 85% |
Efficacy and safety of recombinant factor VIIa for treatment of severe bleeding: A systematic review | 2005 | 183 | 47 | 83% |
Strategies for inhibitor treatment and costs in the short and long term: a critical evaluation of recent clinical studies | 2015 | 1 | 14 | 79% |
Safety update on the use of recombinant factor VIIa and the treatment of congenital and acquired deficiency of factor VIII or IX with inhibitors | 2008 | 44 | 10 | 90% |
Efficacy and safety of recombinant activated factor VII in major surgical procedures | 2008 | 41 | 58 | 86% |
Mechanisms and monitoring of bypassing agent therapy | 2012 | 22 | 53 | 55% |
Recombinant factor VIIa for the prevention and treatment of bleeding in patients without haemophilia | 2007 | 43 | 40 | 85% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | CENT VIRGINIA COAGULAT DISORDERS | 8 | 62% | 0.6% | 8 |
2 | COAGULAT ADVANCEMENT | 4 | 75% | 0.2% | 3 |
3 | ISRAELI HEMOPHILIA | 3 | 50% | 0.4% | 5 |
4 | NOVOSEVEN | 3 | 100% | 0.2% | 3 |
5 | SO ALBERTA HEMOPHILIA CLIN | 3 | 45% | 0.4% | 5 |
6 | TRAITEMENT HEMOPHILES | 3 | 31% | 0.6% | 8 |
7 | BIOPHARMACEUT UNIT | 3 | 17% | 1.1% | 15 |
8 | HAEMOPHILIA THROMBOSIS | 3 | 12% | 1.5% | 21 |
9 | UNITE HEMOSTASE CLIN | 2 | 23% | 0.7% | 9 |
10 | BIOPHARM MFG DEV | 2 | 67% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000191962 | THROMBIN GENERATION//SYN SE BV//PHYS BIOCHEM BLOOD |
2 | 0.0000162974 | PROTHROMBIN COMPLEX CONCENTRATE//PROTHROMBIN COMPLEX CONCENTRATES//ANTICOAGULATION REVERSAL |
3 | 0.0000154710 | FACTOR VIII//FACTOR VIII INHIBITOR//ACQUIRED HEMOPHILIA |
4 | 0.0000136242 | MASSIVE TRANSFUSION//THROMBOELASTOMETRY//THROMBOELASTOGRAPHY |
5 | 0.0000129767 | HAEMOPHILIA//VAN CREVELDKLIN//HEMOPHILIA |
6 | 0.0000107092 | FACTOR VII DEFICIENCY//FACTOR X DEFICIENCY//FACTOR VII |
7 | 0.0000083481 | SECT HEPATOBILIARY SURG LIVER TRANSPLANTAT//AMINO ACIDS THERAPEUTIC USE//LIVER DISEASES COMPLICATIONS |
8 | 0.0000073950 | PSEUDO TUMOURS//HAEMOPHILIC PSEUDOTUMOUR//PSEUDOTUMOUR |
9 | 0.0000062048 | TISSUE FACTOR//TISSUE FACTOR PATHWAY INHIBITOR//TFPI |
10 | 0.0000061775 | APROTININ//TRANEXAMIC ACID//EPSILON AMINOCAPROIC ACID |